Navigation Links
Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint

he treatment of chronic hepatitis B and the safety and efficacy of Viread have not been established in patients coinfected with HBV and HIV. Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued Viread. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who are co-infected with HIV and HBV and discontinue Viread. If appropriate, initiation of anti-hepatitis B therapy may be warranted.

Renal impairment, including cases of acute renal failure and Fanconi syndrome, has been reported in association with the use of Viread. It is recommended that creatinine clearance be calculated in all patients prior to initiating therapy with Viread and as clinically appropriate during therapy. Coadministration of Viread and didanosine should be undertaken with caution. Patients should be monitored closely for didanosine-associated adverse events, and didanosine should be discontinued if these occur. Patients on atazanavir and lopinavir/ritonavir plus Viread should be monitored for Viread-associated adverse events, and Viread should be discontinued if these occur. When co-administered with Viread, it is recommended that atazanavir 300 mg be given with ritonavir 100 mg. Atazanavir without ritonavir should not be co-administered with Viread.

Decreases in bone mineral density (BMD) at the lumbar spine and hip have been seen with the use of Viread. The effects of Viread-associated changes in BMD and biochemical markers on long-term bone health and future fracture risk are unknown. Changes in body fat have been observed in patients taking anti-HIV medicines. The cause and long-term health effect of these changes are unknown. Immune Reconstitution Syndrome has been reported in patients treated with combination therapy, including Viread.

The most common adverse events among patients receiving Viread with other antiretroviral agents in a pivotal clinical s
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/22/2014)... a privately-held medical products and technologies company, today announced ... financial officer of the company, effective July 22, 2014. ... and chief financial officer of Elan Corporation, a ... part of a senior team that helped build significant ... Perrigo, a pharmaceutical manufacturer, in December 2013. ...
(Date:7/22/2014)... 22, 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... R&D outsourcing company with operations in China ... announced that it will release financial results for the second ... on Wednesday, August 13, 2014 (which will be Thursday morning, ... available on the investor relations section of the Company,s website ...
(Date:7/22/2014)... -- According to the American Optometric Association (AOA), parents severely ... An AOA survey reports that 83 percent of children ... use an electronic device for three or more hours ... revealed that only 40 percent of parents believe their ... of time. Eye doctors are concerned that this significant ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4
... RUTHERFORD, N.J., Nov. 1, 2011 Cambrex Corporation (NYSE: ... financial results will be released on Thursday, November 3, ... Company will host a conference call to discuss the ... CallWhen: , Friday, November 4, 2011 at 8:30 a.m. ...
... Fla., Nov. 1, 2011 When you are behind the ... move – looking at vehicles ahead and to the side, ... shifting your gaze inside and outside your vehicle in order ... or change a radio station. During darkness these ...
Cached Medicine Technology:Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark 2Steering Drivers in the Right Direction, "Healthy Vision™ With Dr. Val Jones" Radio Show Offers Information, Advice About Driving in the Dark 3
(Date:7/22/2014)... Texas (PRWEB) July 22, 2014 ... the process of deploying one of the largest physician-centric ... Network ( MHMD ) in Houston. , Created by ... M.D, the DocbookMD application will be embedded into MHMD’s ... “MHMD searched for the best technology to put this ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 The market ... increase in size through 2022, according to new industry ... their appearance can benefit from a new guide published ... for women is now available at http://cherrynews.com/best-nourishing-eye-serum . ... includes instant links to many of the top skin ...
(Date:7/22/2014)... Obtaining a bachelor’s degree in nursing just ... hands-on medical experience. The School of Nursing at The ... launch of an accelerated nursing degree program that provides ... the UNCG Veterans Access Program (VAP), will start January ... some prior college credit, veterans who are RNs can ...
(Date:7/22/2014)... 22, 2014 Mona Khan Company today ... August 15th & 16th, 2014, at the Blanks Studio ... and nationally accredited Bollywood workout was launched in the ... globally appealing Bollywood culture, Bombay Jam® is a dance-based ... follow and designed with authentic Bollywood flavor. Instructor trainings ...
(Date:7/22/2014)... Beach, FL (PRWEB) July 22, 2014 ... that they are now an authorized Daikin comfort pro ... and install Daikin indoor heating and cooling system equipment. ... each one is thoroughly reviewed before being approved. , ... an innovator in the Split System Air Conditioning Market. ...
Breaking Medicine News(10 mins):Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2
... say , MONDAY, Aug. 17 (HealthDay News) -- The first ... has been identified by U.S. researchers. , The new marker ... a T -- in a segment of DNA near the ... They found it by studying the DNA of 1,671 people ...
... First ever-activist toolkit included with an e-book using interactive iPhone technology. ... 17 Former Vermont Governor and DNC Chairman Emeritus Howard Dean ... empower grassroots activism. Dean has teamed up with Vermont-based progressive publisher ... REAL HEALTHCARE REFORM: How We Can Achieve Affordable Medical Care for ...
... , SANTA MONICA, Calif., Aug. 17 Cord Blood ... cell preservation company ( http://www.cord b lood-america.com ... to families nationwide and internationally, said today that its 10Q filing ... of 2009 shows a significantly improved balance sheet. , , ...
... , ... it’s designed to give prospective patients an idea of what the future can hold. Dr. ... plastic surgery in Dallas a view of what they think would look best for ... room. , ...
... ... ... 17, 2009 -- SuperSlow® Zone of Greater Houston has opened its doors to ... 200 provides a one-on-one efficient, effective workout in a cool (68°), studio environment with state-of-the-art ...
... ... databases enable researchers to quickly and effectively use these invaluable resources. , ... Seattle WA (PRWEB) August 17, 2009 -- ... National Cancer Institute,s Cancer Genome Anatomy Project, or CGAP. The Madeline 2.0 Pedigree Drawing ...
Cached Medicine News:Health News:Genetic Discovery May Improve Hepatitis C Treatment 2Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 2Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 3Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 4Health News:Cord Blood America Says Balance Sheet Significantly Strengthened in 2009 2Health News:Cord Blood America Says Balance Sheet Significantly Strengthened in 2009 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 4Health News:SuperSlow Zone Opens in Bunker Hill Village 2Health News:New Online Tutorials for Madeline 2.0 and CGAP from OpenHelix 2Health News:New Online Tutorials for Madeline 2.0 and CGAP from OpenHelix 3
... is an intracorporeal electrokinetic lithotripter particularly ... VIBROLITH guarantees satisfaction in application to ... gall bladder and salivary gland stones. ... percutaneous applications. Kinetic energy transmitted by ...
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
... Multiline offers an ideal combination of ... easy and effective treatment of urinary ... wide range of urological applications. ... images enabling rapid, precise stone localization. ...
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
Medicine Products: